Evidence map›Paper›PMID 30240757›Full record

ArticleiScience2018

Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion.

Laura S Bisogno, Matthew B Friedersdorf, Jack D Keene

Open access · goldAbstract read
In one paragraph

Article in iScience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Prognostic gene biomarkers for c-Src inhibitor Si162 sensitivity in melanoma cells.Turkish journal of biology = Turk biyoloji dergisi · 2024
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Laura S BisognoDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Matthew B FriedersdorfDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Jack D KeeneDepartment of Molecular Genetics & Microbiology, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: jack.keene@dm.duke.edu.
Duke Medical Center · USDuke University Hospital · US

Funding

RNA Dynamics of Transient Macromolecular Complexes in Cancer CellsR01CA157268 · NCI · DUKE UNIVERSITY · PI KEENE, JACK D · 2011 to 2015
$1.7M
Post-transcriptional coordination by HuR and microRNAs during tumorigenesisF31CA185892 · NCI · DUKE UNIVERSITY · PI BISOGNO, LAURA SIMONE · 2014 to 2016
$100k
NCI NIH HHS F31 CA185892NCI NIH HHS R01 CA157268
6 · The paper itself

Abstract

Epithelial-to-mesenchymal transition (EMT) is integral to cancer progression, with considerable evidence that EMT has multiple intermediary stages. Understanding the mechanisms of this stepwise activation is of great interest. We recreated a genetically defined model in which primary cells were immortalized, resulting in migratory capacity, and subsequently H-Ras-transformed, causing malignancy and invasion. To determine the mechanisms coordinating stepwise malignancy, we quantified the changes in messenger RNA (mRNA) and protein abundance. During immortalization, we found dramatic changes in mRNA, consistent with EMT, which correlated with protein abundance. Many of these same proteins also changed following Ras transformation, suggesting that pre-malignant cells were primed for malignant conversion. Unexpectedly, changes in protein abundance did not correlate with changes in mRNA following transformation. Importantly, proteins involved in cellular adhesion and cytoskeletal structure decreased during immortalization and decreased further following Ras transformation, whereas their encoding mRNAs only changed during the immortalization step. Thus, Ras induced EMT-associated invasion via post-transcriptional mechanisms in primed pre-malignant cells.

Indexed as

Cancer Systems BiologyMolecular NetworkTranscriptomics

Identifiers

PMID30240757
PMCPMC6147080
OpenAlexW2804909282

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.